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ABSTRACT
Background and Objectives: Dengue virus infections (Dengue) have become increasingly common in Pakistan and can
result in case fatalities if not managed appropriately. Patients with Dengue virus infection may be asymptomatic or present
with Dengue fever (DF), Dengue with warning signs (DWS) or severe Dengue (SD). Severity in Dengue is coincident with
an exacerbated production of lymphocyte-induced cytokines and chemokines which are associated with plasma leakage. We
investigated the association of circulating levels of cytokines such as Interleukin (IL)-6, tumor necrosis factor (TNF)-alpha
and CXCL-10 in Dengue patients with differing severity of disease.
Materials and Methods: Dengue infection was confirmed by testing for human IgM to the Dengue virus. Dengue patients
(n=58) and healthy controls (n=33) were recruited. Dengue patients were grouped into those with DF (n=39), DWS (n=15)
and SD (n=4). Serum IL-6, TNFα and CXCL10 levels were tested by ELISA. The Mann Whitney U test was used for statistical analysis.
Results: Circulating levels of TNFα (p≤0.001) and CXCL10 (p≤0.001) levels were increased in Dengue patients as compared with controls. When patients were stratified for disease severity, it was observed that CXCL10 was increased in DWS
as compared to DF (p=0.046). IL-6 levels were increased in patients with SD as compared to those with DWS (p=0.044).
TNFα levels were not found to differ between different groups of Dengue patients.
Conclusion: Raised CXCL10 and TNFα levels were associated with increased clinical severity of Dengue infection and probably increased disease progression due to excessive inflammation and increased vascular changes in the
patients.
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Dengue infection caused by the Dengue virus
(DENV) of the Flaviviridae family (1) is a mosquito-borne disease which poses a significant global
burden, infecting between 50-100 million people
per year (2). The virus is rampant in tropical and
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sub-tropical regions, where the climate favors the
rapid growth of the mosquito vector. A variety of factors including overpopulation, poor socio-economic
conditions, lack of public health awareness and excessive flooding have led to the rapid spread of the
disease (3). Dengue is now a serious public health
concern in Pakistan and 21,597 positive cases were
reported in 2015 (4).
Dengue infections have different manifestations
which are classified as per WHO criteria into mild
asymptomatic fever (DF), Dengue with warning
signs (DWS) and severe Dengue (SD) (5). DF is defined as an acute fever with at least two of the following symptoms: nausea, vomiting, rash, aches
and pains, tourniquet test positive and leukopenia.
DWS is characterized by symptoms such as abdominal pain or tenderness, persistent vomiting, mucosal
bleeding, liver enlargement >2 cm, increase in Hematocrit (HCT) concurrent with rapid decrease in
platelet count. Criteria for SD is severe plasma leakage leading to shock and/or fluid accumulation with
respiratory distress; severe bleeding as evaluated by
clinician; severe organ involvement: with raised liver
enzymes Aspartate aminotransferase (AST) or Alanine aminotransferase (ALT) ≥ 1,000, together with
central nervous system (CNS) impairment (5).
Dengue primarily targets mononuclear cells within the leucocyte system. Cells infected with the Dengue virus produce nitric acid and protective pro-inflammatory cytokines such as Interferon-gamma
(IFN-γ), Tumour Necrosis factor-alpha (TNF-α),
interleukin-6 (IL-6) and IL-10 to attract and activate leucocytes at the site of infection (6). TNF-α is
a pro-inflammatory cytokine produced by T cells,
monocytes and endothelial cells to mediates a type1 T cell response (7). IL-6 is a pro-inflammatory,
pleiotropic cytokine that up-regulates inflammatory
responses in macrophages and induces B cell maturation (8). IL-6 is also a pyrogen and induces fever in
patients with dengue. CXCL-10 is an IFN-inducible
chemokine, a chemo-attractant that plays a role in the
innate immune response. CXCL10 binds CXCR3, a
receptor expressed on lymphocytes, and in Dengue
infections, CXCL10 recruits activated T and NK
cells to the site of infection (9).
The relationship between cytokine activation in
the host in response to the pathogen in Dengue infection is complex and makes it difficult to gauge severity of disease. Previous reports have identified a role
of IL-6, TNF-α and CXCL10 in the progression of
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disease in Dengue infections, however, data showing
the association of these cytokines with SD is limited. We investigated the association of the cytokines
TNFα, IL-6 and CXCL10 in patients with differing
Dengue disease severity as compared with healthy
controls. This would allow us to identify markers of
increased disease progression in Dengue infections.

MATERIALS AND METHODS
Subject selection. This was a hospital based case
control study. Dengue virus positive patients diagnosed at the Aga Khan University Hospital (AKUH)
Clinical Laboratory, Karachi were included in the
study. This cohort has been described previously
with ethical approval from the Ethical Review Committee of the Aga Khan University, Pakistan (10).
Here we focused on cases from a subset of Dengue
patients (n=58) from a previous study (10) who were
in-patients at the AKUH. Retrospective review of
patient hospital and laboratory records was conducted. Patients with Dengue infection were categorized
into Dengue fever (DF), Dengue with warning signs
(DWS) and severe Dengue (SD) according to the
2009 WHO guidelines (5). For comparison, healthy
controls (n=33) were also included in the study.
Dengue IgM ELISA. Serum samples were tested
using Panbio Dengue IgM Capture ELISA kit as per
manufacturer’s instruction (Panbio, Australia).
CXCL10, TNF-α and IL-6 measurement. Serum samples were used to measure CXCL10, TNF-α,
and IL-6 levels. ELISA reagents and monoclonal
antibodies for CXCL10 were obtained from R&D
Systems (Abingdon, UK), for TNF-α were obtained
from Thermoscientific (USA) and for IL-6 were obtained from Endogen (Rockford, IL, USA). All measurements were carried out according to the manufacturer’s recommendations. Recombinant human
cytokine was used to obtain a dose response curve
with a range of detection from 6.25–500 pg/ml for
CXCL10, 4.4-1000 pg/ml for TNFα and 6.25-1000
pg/ml for IL-6. Readings for all cytokines were taken at 450 nm and were read off a standard curve.
Statistical analysis. Data are depicted as median
values for each group with the IQR (inter quartile
range 25th-75th percentile) indicated in each case.
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Comparison of non-parametric data between two
groups was performed using the Mann–Whitney
U-test. Analysis was performed and data plotted using GRAPHPAD PRISM Version 5 (GraphPad Software, San Diego, CA, USA).

RESULTS
Characteristics of the study group. A total of 58
patients with Dengue infection were included in this
study and they comprised fifteen cases of DF, thirty
nine cases of DWS and four cases of SD. For comparison, 33 healthy controls who were age and sex
matched were also included in the study. The characteristics of the study population are summarized
in Table 1. Platelet count of study subjects with DF
(p<0.001), DWS (p<0.001) and SD (p=0.0016) were
significantly decreased as compared with healthy

controls (Table 1).
Increased CXCL10 and TNFα levels in patients
with Dengue as compared with healthy controls.
Patients with Dengue had raised levels of CXCL10
(P <0.001) and TNFα (P <0.001) as compared with
healthy controls (Fig. 1). However, IL-6 levels were
found to be comparable between Dengue patients as
compared with controls. To further investigate differential secretion of cytokines as per severity of clinical
Dengue infections, we compared responses between
patients across the clinical spectrum of dengue.
Increased CXCL10 and TNFα are associated
with increased disease severity in Dengue patients. We determined CXCL10, IL-6 and TNFα levels in Dengue patients categorized into DF, DWS and
SD. This data was also compared with the healthy
control group (HC). CXCL10 secretion levels were

Table 1. Characteristics of Dengue patients and healthy controls
Characteristic

HC

Age, mean ± SD, years
Sex, Male (%)
Female (%)
Platelet count, mean ± SD error, platelets/mm3

33±11
M: 8 (53)
F: 7 (47)
279 ±16.2

DF
(n= 15)
24.3 ± 16
9 (60)
6 (40)
156.2 ± 15.8*

DWS
(n= 39)
39.9 ± 24.4
30 (77)
9 (23)
69.9 ± 15.9*

SD
(n= 4)
37 ± 27.3
3 (75)
1 (25)
35.3 ± 14.1*

HC, healthy controls (n=33); Cases with DF, Dengue fever (n=15); DWS, Dengue with warning signs (n=39); SD, Severe
Dengue (n=4). Significant differences (p≤0.05) were calculated between the groups using Mann Whitney U test.

Fig. 1. CXCL10, TNFα and IL-6 levels in patients with Dengue and healthy controls. Serum was collected from healthy controls (HC, 33) and Dengue patients (n=58) and subjected to ELISA to measure CXCL10, TNFα and IL6. Graphs show median
values with standard deviation as y error bars. Data is shown for healthy controls and patients with Dengue for a) CXCL10, b)
TNFα and c) IL-6 secretion levels. Level of significance was defined as P ≤ 0.05. Mann Whitney U test was used to compare
the difference between the two groups.
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increased in each of the Dengue groups; DF (P
<0.001), DWS (P <0.001) and SD (P <0.001) as compared with healthy controls. When comparison was
made between Dengue groups, CXCL10 levels were
also found to be raised in DWS as compared with
DF (P=0.046) (Fig. 2A). TNFα secretion levels were
increased in serum of individual Dengue groups; DF
(P <0.001), DWS (P=0.005) and SD (P=0.004) as
compared with healthy controls (Fig. 2B). There was
no difference in circulating levels of TNFα between
patients with DF, DWS or SD. When serum IL-6 levels were compared between HC and different Dengue groups, it was found that IL-6 levels were similar
(Fig. 2C). However, within Dengue disease severity
groups, IL-6 levels were decreased in DWS as compared with DF (P=0.026) as well as SD (p=0.049).

DISCUSSION
While up-regulation of immune responses, especially cytokine activation, is essential to control viral replication, an excess of cytokines results in increased inflammation and disease progression. Previous reports have shown that there is an increased
profile of pro-inflammatory cytokines in patients
with Dengue fever and Dengue hemorrhagic fever
or Dengue with warning signs have been reported,
however, data for severe Dengue is scanty. We observed that TNFα and CXCL10 levels were raised
in patients with Dengue as compared with healthy
controls. We observed varying circulating cytokine

levels in Dengue patients depending on the severity
of their disease. Particularly, we observed that circulating levels of TNFα and CXCL10 differed between
Dengue patients with severe as compared with mild
disease.
DENV can manipulate host mechanisms for its
own survival and can switch protective Th1 responses to anti-inflammatory Th2 responses which lead to
a more severe hemorrhagic infection (11). Up-regulated expression of anti-inflammatory cytokines such
as IL-6 and IL-10 facilitate Dengue virus replication
and leads to disease progression (12).
Complement factor dysfunctions have been reported in patients with haemorrhagic manifestations
(13). Dengue viral proteins have also been shown to
reduce complement factor production. In addition,
some studies have reported that in infection with
Dengue, massive T cell activation results in the exacerbated production of cytokines resulting in instability in vascular endothelial cell function leading to plasma leakage in advanced stages of disease
(14). Vascular leakage is a hallmark in patients with
severe Dengue (15). One of the leading factors attributed to plasma leakage is T cell induced cytokine
storm. Studies have shown that exacerbated cytokine
secretion alters endothelial permeability resulting in
severe forms of Dengue (16).
The Dengue virus primarily targets monocytes.
TNFα is a monocyte derived pro-inflammatory cytokine. TNFα is known to induce reactive oxygen
and nitrogen intermediates and programs for apoptotic cell death, increasing vascular permeability and

Fig. 2. CXCL10, TNFα and IL-6 levels in patients with Dengue patients with increasing disease severity and healthy endemic
controls. Serum was collected from healthy controls (HC, 33) and Dengue patients categorized into Dengue fever (DF, n=15),
Dengue with warning signs (DWS, n=39) and Severe Dengue (SD, n=4) and subject to ELISA for CXCL10, TNFα and IL6.
Graphs show medians values with standard deviation as y error bars. Data is shown for healthy controls and DF, DHF and DSS
for a) CXCL10, b) TNFα and c) IL-6 secretion levels. Level of significance was defined as P ≤ 0.05. Mann Whitney U test was
used to compare the difference between the two groups.
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ultimately leading to hemorrhage (15). Studies have
shown that increased levels of TNFα are associated with increased vascular permeability in patients
with Dengue. Studies have also shown that TNFα
levels are raised in DWS (17). The role of TNFα in
SD is still unclear. In this study, increased levels of
TNFα observed in Dengue patients as compared with
healthy controls are in line with above findings.
IL-6 is induced by TNFα and IL-1 (18). IL-6 has
been shown to up-regulate c-reactive proteins (CRP)
and secretory phospholipase A2 (sPLA2) and hence
may affect endovascular permeability (18). The data
for IL-6 levels in Dengue patients is variable. Some
show IL-6 levels to be associated with Dengue disease severity (20). However, other studies have also
reported lower levels of IL-6 in patients with shock
(21). Here, we did not find any difference in IL-6
levels between healthy controls and Dengue patients
in general. Lack of any difference in IL-6 levels in
the general group may be due to variation between
groups with differing severity of Dengue. Interestingly, IL-6 levels were lower in DWS as compared
with DF where there were no warning signs. Elevated
levels of IL-6 in SD as compared with patients with
mild Dengue disease may indicate more pathology.
Lower levels of IL-6 in DWS patients may reflect that
these patients might be sampled after few days of infection when IL-6 levels tend to drop followed by an
increase until when shock occurs (21-23).
Up-regulated levels of CXCL10 have previously
been reported in patients infected with the Dengue
virus (26). The increased CXCL10 in patients infected with Dengue virus as compared with controls
observed in this study is in line with the above mentioned findings. CXCL10 has been shown to block
viral entry by binding to heparin sulphate which is
a co-receptor required for Dengue virus to enter the
host cell (9). In this study, CXCL10 levels were found
to be higher in DWS as compared with DF. Our observation that CXCL10 levels in SD were comparable with DWS or DF groups could be due to a limited
sample size in the SD group.
This study had certain limitations. Samples were
taken from patients at a single time point whereas the
cytokine levels are reported to be dynamic and may
differ at different days of illness. Also, it is ideal to
sample a patient immediately after onset of the disease, but most patients seek medical advice after few
days of illness. Another limitation in our study was
the low sample size of patients recruited in the study
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which may not shed enough light on the pathogenesis
of the disease.
Management of Dengue infections is primarily
through supportive care. Our results show variation between IL-6 levels and increase in TNFα and
CXCL10 serum levels to be associated with Dengue
severity. Hence, these cytokines can be used as predictive markers of disease severity. This may assist
in triaging patients as it may be difficult to assess
the severity of disease at the time of diagnosis. Early identification of more advanced disease together
with more proactive management may result in favorable outcomes in severe infections.
In conclusion, increased production of inflammatory mediators ultimately lead to the development of
vascular permeability with poor outcome. If TNFα
and CXCL10 were used as predictive biomarkers of
disease progression, these biomarkers may aid in early identification of patients who are at a higher risk of
more severe forms of Dengue.
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